Background Although cough is a common and distressing symptom in patients with lung cancer, there is almost no evidence to guide treatment. Aprepitant, a centrally acting …
B Patel, J Downie, J Bayliss, A Stephenson… - Journal of Pain and …, 2021 - Elsevier
Background Nausea and vomiting is a common symptom in children through their end of life journey. Aprepitant, a NK-1 antagonist, has become a potent weapon in the fight against …
R Shoulder, J Taylor, H Stiel - Palliative Medicine, 2022 - journals.sagepub.com
Background: Aprepitant, a substance P neurokinin-1 receptor antagonist, is licenced for the prevention of acute and delayed nausea and vomiting associated with highly and …
T Nakayama, K Haratani, T Kurosaki… - Translational Cancer …, 2022 - ncbi.nlm.nih.gov
Background Proper management of chemotherapy-related gastrointestinal toxicities is essential to maximize therapeutic outcome for malignancies. Gastroparesis is an onerous …
OA Vakunenkova, I JuJu, ON Gaykova, AA Kozlov… - mes.fmba.press
METHODS The study involved 140 male Wistar rats (161–190 g) obtained from the Rappolovo laboratory animal nursery. The animals were treated in accordance with the …
ОА Вакуненкова, ЮЮ Ивницкий, КА Краснов… - medline.ru
Резюме Изучали влияние вводимого в желудок гидрокарбоната натрия (NaHCO3) на формирование желудочно-кишечного стаза, острого цитостатического мукозита …
OA Vakunenkova, IJ Ju, KA Krasnov, AA Krasnova - medline.ru
The effect of sodium bicarbonate (NaHCO3) administered by gavage on the formation of gastrointestinal stasis and urinary indican excretion was studied in a rat model of …